Most iPSC labs work with primed pluripotent stem cells without realising there is an alternative state — naïve pluripotency — that has fundamentally different properties for differentiation, chimerism, and disease modelling. NaivaCore is the only HENSM-based medium for naïve iPSC culture available in the EU. This post explains when naïve culture matters and what it requires.
Two states of pluripotency — primed vs naïve
Human pluripotent stem cells exist in two distinct states that differ in their developmental stage, transcriptional programme, metabolic profile, and differentiation capacity:
| Property | Naïve iPSCs | Primed iPSCs (standard) |
|---|---|---|
| Developmental stage equivalent | Pre-implantation epiblast (day 4–6) | Post-implantation epiblast (day 7–14) |
| X chromosome status (female) | Both X active (XaXa) | One X inactivated (XaXi) |
| Mitochondrial metabolism | Oxidative phosphorylation dominant | Glycolysis dominant |
| Chimerism potential | ✅ Contributes to interspecies chimeras (mouse) | ❌ Cannot contribute to chimeras |
| Imprinting erasure | Genome-wide epigenetic reset | Imprinting maintained |
| Differentiation efficiency | Higher for some lineages (trophoblast, PGC) | Standard for most protocols |
| Standard culture medium | HENSM-based (NaivaCore) | mTeSR1, Essential 8, StemFlex |
What is HENSM?
HENSM (Human Embryonic Naïve Stem cell Medium) was developed by the Hanna lab at the Weizmann Institute and published in Nature 2021. It is the current reference formulation for converting primed human iPSCs to naïve pluripotency and for maintaining naïve human PSCs in stable, expandable culture. HENSM contains specific inhibitor combinations (including LIF, bFGF, and PKCi) that maintain the naïve transcriptional programme without requiring feeder cells.
NaivaCore is SeamlessBio’s HENSM-based formulation — the exclusive EU source for this medium — developed to enable naïve iPSC research in European labs without requiring US import, custom formulation, or expensive academic material transfer agreements.
When naïve iPSC culture is the right choice
- Trophoblast and placental research: naïve iPSCs can differentiate into trophoblast stem cells (TSCs) — primed iPSCs cannot. For placental biology, preeclampsia modelling, and early embryo research, naïve cells are essential
- X-chromosome biology: female primed iPSCs have random X inactivation — making it impossible to study X-linked disease without selecting clones with the correct allele inactivated. Female naïve iPSCs have both X chromosomes active — all cells express both alleles. Essential for studying X-linked diseases like Rett syndrome, MECP2 duplication, or Fragile X without clonal selection bias
- Primordial germ cell (PGC) differentiation: naïve iPSCs have significantly higher efficiency for PGC-like cell (PGCLC) induction — relevant for fertility research and gametogenesis studies
- Epigenome studies: naïve cells have undergone global DNA methylation erasure — providing access to the hypomethylated epigenetic state of early embryogenesis that is inaccessible in primed cells
- Cross-species chimerism: for researchers studying interspecies chimera formation (human cells in mouse embryos), naïve cells are required — only naïve human iPSCs can contribute to mouse chimeras
When primed iPSC culture (standard) is sufficient
For most iPSC applications — neural differentiation, cardiomyocyte differentiation, hepatocyte differentiation, drug screening — standard primed iPSCs in mTeSR1 or Essential 8 are the correct choice. The published differentiation protocols are validated for primed cells; adapting them to naïve cells requires significant protocol development. Only switch to naïve culture when the specific properties of naïve pluripotency are required for your research question.
NaivaCore — key technical details
- Format: ready-to-use liquid medium, serum-free, xeno-free
- Compatible cell lines: human iPSCs and ESCs in naïve state; also used for naïve conversion of primed iPSCs
- Feeder requirement: feeder-free protocol available — requires specific coating (laminin-511 or vitronectin recommended)
- Passage: accutase or 0.5 mM EDTA — not TrypLE, which damages naïve iPSC colonies
- Availability: exclusive EU distribution via SeamlessBio — direct supply, no import delays
NaivaCore — HENSM-Based Naïve iPSC Medium, EU Exclusive
SeamlessBio is the exclusive EU source for NaivaCore — the HENSM-based naïve stem cell medium. Direct supply, no import, full technical documentation.
English 
Deutsch